Back
Brookfield Asset Management Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
48
BAM
Brookfield Asset Management
Last Price:
$56.53
Seasonality Move:
-5.26%
Sell
37
DRUG
Bright Minds Biosciences
Last Price:
$37.50
Seasonality Move:
-32.13%
Sell
48
Brookfield Asset Management (BAM)
is a Sell
Is Brookfield Asset Management a Buy, Sell or Hold?
-
The current Brookfield Asset Management [BAM] share price is $56.58. The Score for BAM is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
BAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $37.39. The Score for DRUG is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BAM Stock Price Chart
What is Brookfield Asset Management's stock price today?
-
The Brookfield Asset Management share price today is $56.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $37.39The current trend is relatively stagnant and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
BAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 45.31 | Sell |
Chaikin Money Flow: | 2178325 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.76 - 60.26) | Sell |
Bollinger Bands (100): | (51.86 - 58.72) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 49.78 | Sell |
Chaikin Money Flow: | 27952 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.12 - 42.26) | Buy |
Bollinger Bands (100): | (24.86 - 48.56) | Buy |
BAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.43 | Sell |
20-day SMA: | 58.13 | Sell |
50-day SMA: | 56.75 | Sell |
200-day SMA: | 48.11 | Buy |
8-day EMA: | 57.58 | Sell |
20-day EMA: | 57.82 | Sell |
50-day EMA: | 56.92 | Sell |
200-day EMA: | 50.09 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.75 | Buy |
20-day SMA: | 38.76 | Sell |
50-day SMA: | 37.71 | Sell |
200-day SMA: | 18.92 | Buy |
8-day EMA: | 36.45 | Buy |
20-day EMA: | 37.51 | Sell |
50-day EMA: | 37.11 | Buy |
200-day EMA: | 24.13 | Buy |
Brookfield Asset Management Earnings Growth & BAM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.25 per share, and an increase next year of $0.30 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Brookfield Asset Management Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |